Literature review reveals that HIV infection manifestations in the oral cavity relate to antiretroviral therapy susceptibility, suggesting critical links.
The article reviews the literature which includes data about the relationship between susceptibility to antiretroviral therapy of HIV-positive patients and its manifestation in the oral cavity. The decrease in the number of CD4+ T-lymphocytes leads to the development of secondary diseases in the maxillofacial area. Taking antiretroviral therapy reduces the number of cases of opportunistic diseases: candidiasis, LDE, ulcerative necrotizing periodontitis, herpes virus, “hairy” leukoplakia, with the exception of papillomavirus lesions, non-Hodgkin lymphoma, diseases of unknown etiology.
No takes yet. Share an insight, caveat, or question.
Gaisina et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: